International differences in treatment effect: do they really exist and why?
about
Impact of Human Development Index on the profile and outcomes of patients with acute coronary syndrome.Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX Trial.Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.Detection and Management of Geographic Disparities in the TOPCAT Trial: Lessons Learned and Derivative Recommendations.Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?Influence of practice patterns on outcome among countries enrolled in the SYNTAX trial: 5-year results between percutaneous coronary intervention and coronary artery bypass grafting†.A framework to assess the value of subgroup analyses when the overall treatment effect is significant.Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial.Differences in baseline characteristics, practice patterns and clinical outcomes in contemporary coronary artery bypass grafting in the United States and Europe: insights from the SYNTAX randomized trial and registry.Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis.Globalization of heart failure trials: no turning back on this paradigm.
P2860
Q35135852-9E91C203-64C2-4F58-91F2-D040376E7D05Q37036344-DCDCA5DD-F3A2-49D1-9B80-9C4EFDA8B9B0Q37076243-0580DD5C-1892-43E7-81E8-2C79CD97F6B8Q37341332-D54BC523-D329-4647-BF00-34EEE9B1C4B8Q38731482-FB89B3C8-EDB1-451F-82CA-41C9CE7939A3Q38777054-AFC3379F-9D3B-4130-8A61-B08DBC1F0E37Q38999372-824F4988-7813-4810-8840-96164F347FB1Q39146653-0890725E-BD88-43A3-B1FC-4101C91FAF9FQ45781910-064407D4-06F9-4899-8801-8C9566B19817Q47843525-1661F81B-8F29-4DA1-9CEB-27FE02726931Q53963320-263B39A4-81B9-48FF-AD56-7C74E520BD85
P2860
International differences in treatment effect: do they really exist and why?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
International differences in treatment effect: do they really exist and why?
@en
International differences in treatment effect: do they really exist and why?
@nl
type
label
International differences in treatment effect: do they really exist and why?
@en
International differences in treatment effect: do they really exist and why?
@nl
prefLabel
International differences in treatment effect: do they really exist and why?
@en
International differences in treatment effect: do they really exist and why?
@nl
P2093
P50
P356
P1476
International differences in treatment effect: do they really exist and why?
@en
P2093
Angeles Alonso Garcia
Gonzalo Calvo
Krishna Prasad
Stuart Pocock
P304
P356
10.1093/EURHEARTJ/EHT071
P577
2013-03-07T00:00:00Z